Connection

Andrew Pollard to Viral Vaccines

Back to Details
This is a "connection" page, showing publications Andrew Pollard has written about Viral Vaccines.
Andrew Pollard
Connection Strength
0.140
Viral Vaccines
  1. ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply. Lancet. 2020 11 07; 396(10261):1486-1487.
    View in: PubMed
    Score: 0.048
  2. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020 08 15; 396(10249):467-478.
    View in: PubMed
    Score: 0.047
  3. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines. Vaccine. 2020 06 26; 38(31):4783-4791.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.